Home » FDA Approves Abbott Humira as Ulcerative Colitis Therapy
FDA Approves Abbott Humira as Ulcerative Colitis Therapy
The FDA has approved Abbott’s Humira (adalimumab) for the treatment of adult patients with moderate to severe ulcerative colitis when certain other medicines have not worked well enough.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May